Clinical trials · New York, NY
Diabetes clinical trials in New York
We’re tracking 115 recruiting diabetes studies with a site in or near New York — including Phase 2, Phase 3 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies near New York
- NCT07046767Recruiting
Amnion grafts for slow-healing leg or foot ulcers
This trial tests if a special graft made from amniotic tissue can help heal chronic leg or foot ulcers that haven't improved much in the last month. It may be an option if you have a non-healing venous leg ulcer or diabetic foot ulcer that still shows some signs of healing.
Syosset, New YorkAges 18 years+ - NCT07784270RecruitingPhase 3
Weight loss injection for adults with type 2 diabetes and overweight
This study tests a new injected medicine that may help people with type 2 diabetes and overweight or obesity lose weight. The trial will see how well it works and if it is safe compared to a placebo.
Warren Township, New JerseyAges 18 years+ - NCT07321886RecruitingPhase 3
Study of eloralintide for people with obesity or overweight
This trial tests if an investigational drug called eloralintide can help people with obesity or overweight lose weight. It is for people who do not have type 2 diabetes and who have tried but struggled to lose weight on their own.
Warren Township, New JerseyAges 18 years+ - NCT06546085Recruiting
Extracellular vesicles, insulin, and exercise in type 2 diabetes
This study looks at how tiny particles called extracellular vesicles affect how your body uses insulin, and whether exercise can make a difference. It is for people with type 2 diabetes (or normal blood sugar) who are not very active and have been on diabetes medication for a long time.
New Brunswick, New JerseyAges 30–80 - NCT06834204Enrolling by invitation
Better care coordination for cancer survivors
This study tests a program to improve communication between your cancer team and your regular doctor. If you have heart or diabetes risks and you're being treated for breast, prostate, bladder, or endometrial cancer, this trial may help coordinate your care.
New Brunswick, New JerseyAges 18 years+ - NCT06814184Recruiting
Virtual diabetes care for adults with type 2 diabetes on Medicaid and insulin
This study tests a virtual (remote) diabetes care program for adults with type 2 diabetes who are on insulin and have Medicaid insurance. It aims to help improve blood sugar control using a smartphone app or text messages.
New Brunswick, New JerseyAges 18–90 - NCT05785780Enrolling by invitation
Help improve colon cancer screening for people with diabetes
This study looks for better ways to make sure people with diabetes get up-to-date colon cancer screening. If you haven’t had the recommended test on time, it may help identify barriers in primary care and improve screening follow-through.
New Brunswick, New JerseyAges 50–74 - NCT07197788Enrolling by invitation
Continued access to the Endogenex device study for type 2 diabetes
This trial offers continued access to the Endogenex system for people who were in the sham (placebo) group of the ReCET study and have completed their 12-month visit. It tests a device that treats the duodenum to improve blood sugar control.
New Brunswick, New JerseyAges 22 years+ - NCT06663813Recruiting
Preventing diabetes complications for ER patients
This trial offers counseling and support to emergency department patients with high blood sugar to help them adopt healthy habits and prevent diabetes-related problems.
New Brunswick, New JerseyAges 18 years+ - NCT06136793Enrolling by invitation
Healthy home habits for Chinese-heritage adults
This study tests a program to help Chinese-heritage adults with heart or diabetes conditions adopt healthier eating and lifestyle habits at home. It includes online resources and support to make lasting changes.
New Brunswick, New JerseyAges 30–70 - NCT07776509RecruitingPhase 3
Adding a new drug to current weight-loss therapy for adults with obesity or overweight
This study tests a new medication (AZD6234) added to your current weight-management medication (an incretin-based drug) to see if it helps with weight loss. You may be eligible if you are overweight or obese with related health issues or type 2 diabetes.
Somerset, New JerseyAges 18 years+ - NCT03937453Recruiting
Pancreatic cancer screening for people with new or worsening diabetes
This study checks whether regular imaging can find pancreatic cancer earlier in people who recently developed diabetes or whose diabetes is getting worse. It may help detect pancreatic problems sooner when treatment options are likely better.
Norwalk, ConnecticutAges 50 years+ - NCT02795052Recruiting
Stem cell treatment trial for nerve injury
This study tests whether bone-marrow stem cells can improve nerve function in people with nerve damage that usually doesn’t recover with current care. It also checks whether the treatment is safe and whether people can be followed over time with repeated nerve exams.
Westport, ConnecticutAges 18 years+ - NCT07684144RecruitingPhase 3
Long-term study of a weight-loss medication for people who completed an earlier trial
This study tests the long-term effects of a medication called maridebart cafraglutide for weight management. It is for people who already completed a 72-week study of this drug and want to continue treatment.
Trenton, New JerseyAges 18–99 - NCT07209475RecruitingPhase 4
Amnio-Maxx for healing diabetic foot ulcers
This trial tests whether a special wound dressing called Amnio-Maxx can help heal foot ulcers in people with diabetes. You may qualify if you have a diabetic foot ulcer that hasn't healed much with standard care.
East Patchogue, New YorkAges 18 years+ - NCT07662044RecruitingPhase 3
Studying elecoglipron for type 2 diabetes
This trial tests a new medicine called elecoglipron, taken alone or with another diabetes drug (dapagliflozin), to see if it helps control blood sugar better than a placebo. It may be an option if your current treatment isn't working well enough.
Bridgeport, ConnecticutAges 18 years+ - NCT07662213RecruitingPhase 3
Elecoglipron vs semaglutide for type 2 diabetes
This study tests an experimental diabetes pill (elecoglipron) to see if it works as well as a current medicine, semaglutide, for people with type 2 diabetes who also have heart risk factors. It aims to help better control blood sugar and weight.
Bridgeport, ConnecticutAges 18 years+ - NCT07414368Enrolling by invitation
StimLabs umbilical cord material for wound healing
This study looks at how a wound treatment made from donated human umbilical cord tissue works for both new and long-lasting wounds. The treatment is a dehydrated powder that is applied directly to the wound.
Bridgeport, ConnecticutAges 18 years+ - NCT06962839RecruitingPhase 2
Study of BI 1815368 for diabetic macular edema
This trial tests an experimental medication (BI 1815368) given as an eye injection for people with diabetic macular edema, a condition where fluid builds up in the center of the retina and blurs vision. The study aims to see if this new treatment can reduce swelling and improve vision.
Danbury, ConnecticutAges 18 years+
Hear when a new Diabetes trial opens near New York, NY
We’ll email you when one opens near New York, NY — at most once a week, no account needed, unsubscribe anytime.
Diabetes trials in other cities
Where these studies are running near New York
Institutions with a site for the recruiting diabetes studies listed above.
- Research Site · 4 studies
- Connecticut Eye Consultants, P.C.
- Family Foot & Ankle Specialists, LLC
- IMA Clinical Research Warren
- Institute for Food, Nutrition, and Health
- Jevlos Health, Inc
- MD Stem Cells
- Nuvance Health
What taking part in a diabetes study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting diabetes studies in New York.
Common questions
- Are there diabetes clinical trials near New York?
- Yes. We're currently tracking 115 recruiting diabetes studies with a site near New York, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a diabetes study near New York?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in New York to take part?
- Not necessarily. These studies have a site near New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a diabetes trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New diabetes studies open near New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.